Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy

In some areas of the world, antiviral therapy for chronic hepatitis C (CHC) is not available for all patients. The optimal interval for liver stiffness measures (LSM) and noninvasive scores to assess fibrosis progression has not been studied. We evaluated the usefulness of consecutive LSM, APRI, FIB-4 and Forns scores to predict disease progression.

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2BFtmOi
via IFTTT